WHO WE ARE
FCF is a specialized Investment Bank and Financing Specialist, advising public and private mid-market companies in the German speaking regions:
- Mid-market clients with an annual turnover of EUR 100 million to EUR 1 billion primarily within the traditional German industries such as Automotive, Communications, Industrials, Machinery, Pharma & Healthcare, Renewables, Software & IT, Transportation & Logistics
- High-growth and venture-type companies in R&D- and patent-driven segments such as Life Sciences and Real-Technology
FCF arranges, structures, and places equity and debt capital and supports its clients’ growth, IPO/Pre-IPO, acquisition and standard balance sheet (re-)financing strategies.
WHO WE SERVE
WHAT WE DO
(click below for details)
- with the best conditions,
- with the highest flexibility,
- in the shortest period of time,
- with the highest closing probability,
- with long-lasting financial partners that suit the company’s objectives.
- Deep knowledge and understanding of all relevant financial instruments across the debt and equity space:
- 360-degree perspective, offering maximum independence and freedom
- Complete financial markets insight with direct access to all relevant institutional investors and financiers
- Strategic approach in searching and selecting suitable investors
- Development, structuring and placing of comprehensive financial solutions combined with targeted financing measures
- The most creative team, specialized in the financing of SMEs
- Proactive, independent process management for strengthened negotiation leverage
- Focus on SMEs in the DACH region
- Quintessential medium-sized companies (“Mittelstand”) with revenues between EUR 100m and EUR 1,000m
- Fast growing companies operating established and proven business models
- Ultra-high growth, innovative companies with revolutionary technologies / products, for instance in life science and high-tech
- Access to & established network with the largest families, family offices and Ultra High Net Worth investors
- Discrete, bilateral discussions behind closed doors
- Direct investments with entrepreneurial and co-operative approach
- Long-term investment horizons all the way to evergreen funding
- Direct access to key executives at all top-tier and mid-sized investment banks
- to the market-leading, market-influencing sector experts
- to investment banking, capital markets and research departments
- Top-tier institutional US investors with focus on and interest in DACH enterprises
- Contact to selected “high profile” Ultra High Net Worth investors and family offices
- Exclusive dialog with the entrepreneurs / owners
- 100% focus on the requirements and interests
- Confidant and creative motivator in the decision-making process
- Maximization of alternative courses of action
RECENT TRANSACTIONS
Synapticon GmbH
December 2018
> € 10 million
Investment in
December 2018
> € 10 million
GSE Group Acquisition by Finexx
December 2018
[amount confidential]
GSE Group Acquisition by Finexx
November 2018
[amount confidential]
RECENT NEWS
Some disillusionment-but also a little bit of hope, Biotech in Bavaria–Report 2018/19
FCF Fox Corporate Finance contributes to the to the Biotech in Bavaria – Report 2018/19 with “Some disillusionment – but also a little bit of hope”, published by BioM Biotech Cluster Development GmbH.
Venture Debt Summit 2019 | European Investment Bank, Luxembourg
The European Investment Bank (EIB) organized its 2nd Venture Debt Summit 2019 on 28th March 2019 and hosted around 100 CEO/CFOs of the portfolio companies, their private funds sponsors, financial advisors, the European Commission, EIB
FCF at 3rd European Chemistry Partnering
“STRATEGIC FINANCE IN LIFE SCIENCES & CHEMISTRY” Workshop Summary The workshop provided an in-depth insight into the various financing opportunities, from early stage venture financing to bank debt financing, available to companies in the chemical